Balogh Z

References (8)

Title : Involvement of 2-arachidonoylglycerol signaling in social challenge responding of male CD1 mice - Aliczki_2015_Psychopharmacology.(Berl)_232_2157
Author(s) : Aliczki M , Varga ZK , Balogh Z , Haller J
Ref : Psychopharmacology (Berl) , 232 :2157 , 2015
Abstract : Aliczki_2015_Psychopharmacology.(Berl)_232_2157
ESTHER : Aliczki_2015_Psychopharmacology.(Berl)_232_2157
PubMedSearch : Aliczki_2015_Psychopharmacology.(Berl)_232_2157
PubMedID: 25547462

Title : The temporal dynamics of the effects of monoacylglycerol lipase blockade on locomotion, anxiety, and body temperature - Aliczki_2012_Behav.Pharmacol_23_348
Author(s) : Aliczki M , Balogh Z , Tulogdi A , Haller J
Ref : Behav Pharmacol , 23 :348 , 2012
Abstract : Aliczki_2012_Behav.Pharmacol_23_348
ESTHER : Aliczki_2012_Behav.Pharmacol_23_348
PubMedSearch : Aliczki_2012_Behav.Pharmacol_23_348
PubMedID: 22750842

Title : Correlation between the activities of lipoprotein lipase and paraoxonase in type 2 diabetes mellitus - Kalmar_2005_Diabetes.Metab_31_574
Author(s) : Kalmar T , Seres I , Balogh Z , Kaplar M , Winkler G , Paragh G
Ref : Diabetes Metab , 31 :574 , 2005
Abstract : Kalmar_2005_Diabetes.Metab_31_574
ESTHER : Kalmar_2005_Diabetes.Metab_31_574
PubMedSearch : Kalmar_2005_Diabetes.Metab_31_574
PubMedID: 16357806

Title : Effect of short term treatment with simvastatin and atorvastatin on lipids and paraoxonase activity in patients with hyperlipoproteinaemia - Paragh_2004_Curr.Med.Res.Opin_20_1321
Author(s) : Paragh G , Torocsik D , Seres I , Harangi M , Illyes L , Balogh Z , Kovacs P
Ref : Curr Med Res Opin , 20 :1321 , 2004
Abstract : Paragh_2004_Curr.Med.Res.Opin_20_1321
ESTHER : Paragh_2004_Curr.Med.Res.Opin_20_1321
PubMedSearch : Paragh_2004_Curr.Med.Res.Opin_20_1321
PubMedID: 15324535

Title : The effect of micronised fenofibrate on paraoxonase activity in patients with coronary heart disease - Paragh_2003_Diabetes.Metab_29_613
Author(s) : Paragh G , Seres I , Harangi M , Balogh Z , Illyes L , Boda J , Szilvassy Z , Kovacs P
Ref : Diabetes Metab , 29 :613 , 2003
Abstract : Paragh_2003_Diabetes.Metab_29_613
ESTHER : Paragh_2003_Diabetes.Metab_29_613
PubMedSearch : Paragh_2003_Diabetes.Metab_29_613
PubMedID: 14707891

Title : Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates? - Balogh_2001_Diabetes.Metab_27_604
Author(s) : Balogh Z , Seres I , Harangi M , Kovacs P , Kakuk G , Paragh G
Ref : Diabetes Metab , 27 :604 , 2001
Abstract : Balogh_2001_Diabetes.Metab_27_604
ESTHER : Balogh_2001_Diabetes.Metab_27_604
PubMedSearch : Balogh_2001_Diabetes.Metab_27_604
PubMedID: 11694861

Title : Serum paraoxonase activity changes in uremic and kidney-transplanted patients - Paragh_1999_Nephron_83_126
Author(s) : Paragh G , Asztalos L , Seres I , Balogh Z , Locsey L , Karpati I , Matyus J , Katona E , Harangi M , Kakuk G
Ref : Nephron , 83 :126 , 1999
Abstract : Paragh_1999_Nephron_83_126
ESTHER : Paragh_1999_Nephron_83_126
PubMedSearch : Paragh_1999_Nephron_83_126
PubMedID: 10516491

Title : The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia - Paragh_1998_Nephron_80_166
Author(s) : Paragh G , Seres I , Balogh Z , Varga Z , Karpati I , Matyus J , Ujhelyi L , Kakuk G
Ref : Nephron , 80 :166 , 1998
Abstract : Paragh_1998_Nephron_80_166
ESTHER : Paragh_1998_Nephron_80_166
PubMedSearch : Paragh_1998_Nephron_80_166
PubMedID: 9736814